These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 2001760

  • 1. The effect of 6 weeks of testosterone treatment on pulsatile luteinizing hormone secretion in eugonadal female-to-male transsexuals.
    Scheele F, Hompes PG, Gooren LJ, Spijkstra JJ, Spinder T.
    Fertil Steril; 1991 Mar; 55(3):608-11. PubMed ID: 2001760
    [Abstract] [Full Text] [Related]

  • 2. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects.
    Spinder T, Spijkstra JJ, van den Tweel JG, Burger CW, van Kessel H, Hompes PG, Gooren LJ.
    J Clin Endocrinol Metab; 1989 Jul; 69(1):151-7. PubMed ID: 2471710
    [Abstract] [Full Text] [Related]

  • 3. Effects of long-term testosterone administration on gonadotropin secretion in agonadal female to male transsexuals compared with hypogonadal and normal women.
    Spinder T, Spijkstra JJ, Gooren LJ, Hompes PG, van Kessel H.
    J Clin Endocrinol Metab; 1989 Jan; 68(1):200-7. PubMed ID: 2491861
    [Abstract] [Full Text] [Related]

  • 4. Pulsatile luteinizing hormone release and ovarian steroid levels in female-to-male transsexuals compared to heterosexual women.
    Spinder T, Spijkstra JJ, Gooren LJ, Burger CW.
    Psychoneuroendocrinology; 1989 Jan; 14(1-2):97-102. PubMed ID: 2499904
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F.
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [Abstract] [Full Text] [Related]

  • 6. Effects of ethinyl estradiol on semen quality and various hormonal parameters in a eugonadal male.
    Lübbert H, Leo-Rossberg I, Hammerstein J.
    Fertil Steril; 1992 Sep; 58(3):603-8. PubMed ID: 1387850
    [Abstract] [Full Text] [Related]

  • 7. Short-term patterns of pulsatile luteinizing hormone secretion do not differ between male-to-female transsexuals and heterosexual men.
    Spijkstra JJ, Spinder T, Gooren LJ.
    Psychoneuroendocrinology; 1988 Sep; 13(3):279-83. PubMed ID: 3406325
    [Abstract] [Full Text] [Related]

  • 8. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC, Pache TD, Lamberts SW, Hop WC, de Jong FH, Dahl KD.
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [Abstract] [Full Text] [Related]

  • 9. The effect of non-steroidal antiandrogen flutamide on luteinizing hormone pulsatile secretion in male-to-female transsexual subjects.
    Giusti M, Falivene MR, Carraro A, Cuttica CM, Valenti S, Giordano G.
    J Endocrinol Invest; 1995 Jun; 18(6):420-6. PubMed ID: 7594235
    [Abstract] [Full Text] [Related]

  • 10. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S, Kondoh K, Kubo T.
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [Abstract] [Full Text] [Related]

  • 11. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM, Baus S, Kliesch S, Keck C, Simoni M, Nieschlag E.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [Abstract] [Full Text] [Related]

  • 12. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [Abstract] [Full Text] [Related]

  • 13. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D, Steingold K, Cedars M, Lu JK, Meldrum DR, Judd HL, Chang RJ.
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [Abstract] [Full Text] [Related]

  • 14. Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men.
    Wiegelmann W, Solbach HG, Kley HK, Nieschlag E, Rudorff KH, Krüskemper HL.
    Horm Res; 1976 Jun; 7(1):1-10. PubMed ID: 793974
    [Abstract] [Full Text] [Related]

  • 15. Sex steroids and pulsatile luteinizing hormone release in men. Studies in estrogen-treated agonadal subjects and eugonadal subjects treated with a novel nonsteroidal antiandrogen.
    Gooren L, Spinder T, Spijkstra JJ, van Kessel H, Smals A, Rao BR, Hoogslag M.
    J Clin Endocrinol Metab; 1987 Apr; 64(4):763-70. PubMed ID: 3102546
    [Abstract] [Full Text] [Related]

  • 16. Modulation of pulsatile gonadotropin secretion by testosterone in man.
    Matsumoto AM, Bremner WJ.
    J Clin Endocrinol Metab; 1984 Apr; 58(4):609-14. PubMed ID: 6421864
    [Abstract] [Full Text] [Related]

  • 17. Effects of gonadotropin-releasing hormone pulse-frequency modulation on luteinizing hormone, follicle-stimulating hormone and testosterone secretion in hypothalamo/pituitary-disconnected rams.
    Wu FC, Irby DC, Clarke IJ, Cummins JT, de Kretser DM.
    Biol Reprod; 1987 Oct; 37(3):501-10. PubMed ID: 3118979
    [Abstract] [Full Text] [Related]

  • 18. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
    Apter D, Bützow T, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):119-25. PubMed ID: 8027216
    [Abstract] [Full Text] [Related]

  • 19. Increased frequency of pulsatile luteinizing hormone-releasing hormone administration selectively decreases follicle-stimulating hormone levels in men with idiopathic azoospermia.
    Gross KM, Matsumoto AM, Berger RE, Bremner WJ.
    Fertil Steril; 1986 Mar; 45(3):392-6. PubMed ID: 3081382
    [Abstract] [Full Text] [Related]

  • 20. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM, Gow SM, Wu FC.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.